SBIR/STTR Research Award
AZAANTHRACENEDIONES AS ANTITUMOR AGENTS
Award amount
$50,000Program and phase
SBIR · Phase IAward year
1987Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Humphrey Chemical Company
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
THE OBJECTIVE OF THIS PROPOSAL IS AN INTEGRATION OF A CHEMICAL AND BIOLOGICAL APPROACH TO THE COMMERCIAL DEVELOPMENT OF A NEW HETEROCYCLIC ANTITUMOR AGENT. HUMPHREYCHEMICAL COMPANY PROPOSES TO SYNTHESIZE AND BIOLOGICALLY EVALUATE A SERIES OF AZAANTHRACENE-9,10-DIONES. THE GOAL IS THE COMMERCIALIZATION OF AN ANTITUMOR AGENT THAT LACKS THE INHERENT CARDIOTOXICITY CURRENTLY EXHIBITED BY ANTINEOPLASTIC AGENTS SUCH AS MITOXANTRONE.
Technology keywords
Not reported